Abel's Debut Quarter: A Clean P&L Reset, A Continuity Letter, And No Capital-Deployment Catalyst

Results vs. Consensus

Quality of the Miss

• Operating EPS: The 8.9% Street miss was almost entirely driven by the insurance reset. Operating revenues decreased 0.7% year over year to $94.2 billion; the top line missed the consensus estimate by 8.4%. Importantly, the consensus had embedded an +8.4% revenue lift — meaning the Street was modeling an entirely different insurance pricing trajectory than the one Berkshire actually delivered.
• GAAP vs. operating divergence: Headline GAAP EPS was nearly flat YoY because net earnings included $13.49B of investment gains in Q4, partly offset by the $4.5B Kraft Heinz / Occidental OTTI. Per Berkshire's longstanding framing, the GAAP swing is largely a mark-to-market artifact. The clean read is operating earnings, where the deterioration is real and broad-based across the insurance complex.
• Insurance: Both legs — underwriting and investment income — moved against Berkshire simultaneously. The combined insurance line dropped from $7.50B to $4.63B in Q4 alone. That is the entire YoY shortfall in operating earnings, mathematically.
• Non-insurance held up: BNSF, Manufacturing/Service/Retailing, and BHE were collectively a slight tailwind. The non-insurance complex is doing what it should do — generating durable cash flow that compounds while the insurance cycle rolls.

Segment Performance — Full Year & Q4 ($M)

Insurance — Where the Quarter Was Lost

The insurance complex carried the entire deterioration. Insurance underwriting generated $1.56B in operating earnings in Q4 2025 vs. $3.41B in Q4 2024; for the full year, $7.26B vs. $9.02B. The decline was not a one-quarter event — it ran across all three reporting segments.

GEICO bore the largest dollar share of the FY decline. GEICO generated pre-tax underwriting earnings of $6.8 billion in 2025 vs. $7.8 billion in 2024, as premiums earned increased over 5% to $44.5 billion. Losses and LAE rose 6% YoY to $32.1 billion, while underwriting expenses increased 34.2% to $5.5 billion. A higher loss ratio of 72.3% and a higher expense ratio of 12.4% resulted in a combined ratio of 84.7% for GEICO in 2025, higher than 2024's 81.5%. Abel was straightforward about the trade-off:

"GEICO's broad rate increases in recent years have restored margins but come at the cost of lower retention. Competitors' rate reductions may extend that pressure into 2026… Restoring retention while maintaining underwriting discipline will take time." — Greg Abel, CEO, 2025 Letter

The reinsurance group was the bigger percentage decliner. At Berkshire Hathaway Reinsurance Group, pre-tax underwriting earnings declined by more than 32% year-on-year to $1.9 billion, driven by a decline in property to $3.2 billion from $3.8 billion in 2024. Management's diagnosis is structural rather than transient — the cycle has turned because capital came in, not because Berkshire underperformed:

"The reinsurance sector has attracted significant increases in available capital from both the traditional and alternative markets, which together with a more benign reinsured catastrophe loss burden in 2025 in most major regions has led to significant price declines in property reinsurance. In most casualty reinsurance segments, claims inflation continued to outpace pricing. As long as these phases of the cycle endure, we expect to write less reinsurance premium." — Greg Abel, CEO, 2025 Letter

The float, however, kept growing. Berkshire Hathaway's float grew from approximately $171 billion at the end of 2024 to around $176 billion at the end of 2025. Float at $88B in 2015 has effectively doubled in a decade. The pricing cycle hurts current-period earnings; the float compounds regardless.

Assessment: The insurance reset is the central fact of the quarter, and management is asking investors to accept lower volume in exchange for preserved underwriting discipline. That is the correct trade for a long-term holder, but it removes a key earnings tailwind for the next several quarters.

BNSF — The Operational Bright Spot, And The First Real Abel Accountability Marker

BNSF's full-year operating earnings rose to $5.48B from $5.03B (+8.8%), and Abel disclosed the operating margin specifically: 34.5% in 2025 vs. 32.0% in 2024. The improvement is real but, by Abel's own framing, insufficient.

"The gap to the industry's best remains too wide and closing it will require continued improvements in efficiency and service. Each one-percentage-point improvement in operating margin generates approximately $230 million of incremental operating cash flow for our owners. The team recognizes the significance of this opportunity, and we will be disappointed if we do not deliver a substantial improvement over the next few years." — Greg Abel, CEO, 2025 Letter

This is the most pointed accountability language in the letter. Naming a specific dollar conversion ($230M per 100bps) and using "disappointed if we do not deliver" is a step away from the Buffett-era framing of letting managers operate without quarterly pressure. Katie Farmer is already on the agenda for the May 2026 annual meeting Q&A.

Assessment: BNSF margin is the most quantifiable Abel-era catalyst in the entire enterprise. If the railroad closes even half the gap to peer-best operating ratios over the next several years, the cumulative cash-flow impact materially supports per-share intrinsic value. This is the operational thesis to track quarter-by-quarter.

BHE — Stable Cash, AI Demand on the Horizon, Wildfire Tail Still Unresolved

BHE delivered $3.98B FY operating earnings (+6.7%), with Q4 modestly down. The bigger story is the demand setup. Abel explicitly named the AI/data-center driver, but with a discipline qualifier:

"Infrastructure built for hyperscalers and data centers must be paid for by those customers and reflect the risks tied to step-changes in long-term demand. BHE will pursue this incremental growth and invest our shareholders' capital only when those risks and rewards are appropriately balanced." — Greg Abel, CEO, 2025 Letter

On wildfire, Abel acknowledged PacifiCorp's settlements related to the 2020 Labor Day fires but drew a clear line: PacifiCorp "is not an insurer of last resort and should not be treated as a deep pocket." The legal tail remains an open exposure.

Assessment: BHE is positioned for the AI capex super-cycle, but management has signaled it will not chase that growth on terms that compress utility-style returns. That is consistent with Berkshire's discipline — it also caps near-term acceleration. Wildfire risk remains a binary tail.

Manufacturing, Service & Retailing — Quietly the Most Reliable Compounder

MSR generated $13.65B FY operating earnings (+4.4% YoY), with Q4 up 3.3%. Within that, Precision Castparts is the segment-level story:

"In 2025, Precision Castparts generated $2.4 billion of net cash flows from operating activities, compared to an average of $0.9 billion in 2021 and 2022 and $1.7 billion in 2015, the last full fiscal year before our acquisition." — Greg Abel, CEO, 2025 Letter

The aerospace-cycle recovery has finally pulled Precision Castparts above its pre-acquisition cash generation, validating the original thesis after a decade of pandemic-era pain. Lubrizol's Rebecca Liebert is also being assigned the OxyChem integration, which is a meaningful management depth signal.

Assessment: The MSR segment is doing what it is supposed to do — generating durable, lightly capital-intensive cash that flows up to the parent. With OxyChem joining post-period (closed January 2, 2026), this segment becomes structurally larger in 2026.

Key Topics & Management Commentary

Overall Management Tone: Abel's debut letter was deliberately a continuity statement — substantively a re-articulation of Berkshire's foundational values rather than a strategic update. Where the letter departed from Buffett-era pattern, it did so in a single direction: more direct accountability language for specific operating businesses (BNSF margins, GEICO retention, Pilot's Pro Preference rank, Shaw's self-inflicted execution slips). That subtle shift, more than any individual operational data point, is the signal worth tracking.

The Cash Pile and Capital Deployment

The most-asked question entering this print was what Abel intended to do with Berkshire's cash. Berkshire's cash pile stood at $373.3 billion at the end of 2025. Abel addressed it head-on:

"Our cash and U.S. Treasury holdings now exceed $370 billion. While some of this capital is required to support our insurance operations and protect Berkshire against extreme scenarios, it also constitutes our dry powder. There will undoubtedly be incremental opportunities to deploy our owners' capital without compromising Berkshire's resilience. My role is to ensure our liquidity levels and capital deployment remain intentional and deliberate. We will always aim for ownership of productive businesses over U.S. Treasuries." — Greg Abel, CEO, 2025 Letter

And explicitly pushing back on the "retreat from investing" narrative:

"Many times in Berkshire's history, some observers have suggested that our substantial cash position signals a retreat from investing. It does not. We continue to evaluate many opportunities and will remain patient and disciplined in pursuing the right ones for the benefit of our owners." — Greg Abel, CEO, 2025 Letter

Two 2025 deals were named: OxyChem (closed January 2, 2026) and Bell Laboratories (rodent control — Abel quoted CEO Steve Levy describing it as "high operating margins, very good historical growth and future growth potential, easy to understand and always needed, and a strong management team," and added "We only wish it had been ten times bigger.")

What is conspicuously absent is any acceleration of buybacks. BRK.B did not repurchase shares in 2025. The criterion remains unchanged — repurchase only below intrinsic value, conservatively determined — but the implicit message is that Berkshire's own shares were not below management's intrinsic-value estimate at any point in 2025, even after the stock pulled back from its May high.

Assessment: Cash is dry powder, not idle. But "dry powder" needs an opportunity to become a thesis — and at $373B the bar for what counts as a "scaled" deployment is high. The Street will read continued cash accumulation in 2026 as a deferred catalyst, not a permanent overhang.

Kraft Heinz and Occidental — The Buffett-Era Cleanup

The single most strategically important move in this print was the impairment. Results included other-than-temporary impairment charges of $4.50 billion in the fourth quarter and $8.26 billion for the full year related to investments in Kraft Heinz and Occidental. Abel was direct in the letter:

"We also hold equity method investments, principally Kraft Heinz and Occidental. Our investment in Kraft Heinz has been disappointing. Even after considering the preferred equity component in our original Heinz investment, our return has been well short of adequate." — Greg Abel, CEO, 2025 Letter

Taking the OTTI in Q4 — Abel's first quarter — rather than letting these positions continue to mark-to-market against future-Abel earnings is a clean baseline-resetting move. The implication is that Abel's future capital-allocation track record will be measured from a cleaner starting carrying value, not against the goodwill of two long-stewing problem holdings.

Assessment: This is structurally healthy for the new CEO. The optics — a $4.5B Q4 charge driving the GAAP-vs.-operating divergence — are ugly. The economics — clearing decks before owning the next chapter of the equity portfolio — are correct.

The Equity Portfolio — Concentration With Selective Adjustments

Abel re-anchored the named "core" equity holdings around four U.S. names — Apple, American Express, Coca-Cola, and Moody's — combined market value $158.6B at year-end. Conspicuously absent from that list is Bank of America, which had been the third-largest holding entering 2025. The omission is the equity-portfolio signal of the letter.

"This concentrated approach will continue, with limited activity in these holdings, though we may significantly adjust a holding if we see fundamental changes in its long-term economic prospects." — Greg Abel, CEO, 2025 Letter

The Japanese trading-house basket was reaffirmed at $35.4B market value across Mitsubishi, ITOCHU, Mitsui, Marubeni, and Sumitomo, financed at an average 1.2% yen-borrowing cost — a structurally attractive carry trade in addition to the equity exposure.

On the management seat:

"At Berkshire, equity investments are fundamental to our capital allocation activities; responsibility ultimately resides with me as CEO. Ted Weschler manages about 6% of our investments, including a portion of the portfolio formerly overseen by Todd Combs." — Greg Abel, CEO, 2025 Letter

Assessment: Abel is keeping the equity portfolio on the same disciplined, concentrated track but explicitly claiming ownership of allocation decisions. That removes ambiguity about whether the portfolio framework would migrate to the deputies post-Buffett — it will not. The Bank of America de-emphasis is the most notable change, and is likely to draw further trimming activity in subsequent 13F filings.

Operating Cash Flow vs. Earnings — The Metric Abel is Anchoring On

Abel made a deliberate choice in this letter to repeatedly cite net operating cash flow alongside (and often instead of) GAAP earnings as the per-business performance benchmark. In 2025, Berkshire produced $46 billion of net cash flows from operating activities, compared to a five-year average of more than $40 billion.

This is consistent with prior Berkshire framing but the consistency-of-cite is new. The per-business cash-flow disclosures in the letter (BNSF $8.1B, BHE $8.4B, Pilot $1.7B, Precision Castparts $2.4B) function as quasi-segment KPIs — the closest thing Berkshire has to formal segment guidance. Investors should mentally re-anchor their mental model around these numbers rather than the press-release operating-earnings line in 2026 and beyond.

Assessment: If Abel is going to be measured on cash-flow conversion at the operating-business level rather than headline EPS, the multiple-on-earnings frame becomes structurally less useful. Track per-business operating cash flow YoY and the BNSF margin specifically — those are Abel's chosen yardsticks.

Management Transitions and Bench Depth

Several personnel data points in the letter materially affect the post-Buffett bench:

• CFO Marc Hamburg retiring effective June 1, 2027, transitioning CFO responsibilities a year prior on June 1, 2026 to Chuck Chang.
• Mike O'Sullivan welcomed as Berkshire's first General Counsel.
• Adam Johnson now serving as president of consumer products, service, and retailing — 30 years at Berkshire (10 as CEO of NetJets) — overseeing 32 companies.
• Lubrizol CEO Rebecca Liebert assigned dual-hat responsibility integrating OxyChem alongside CEO Wade Alleman.
• Annual meeting May 2, 2026 features two Q&A sessions — Abel + Ajit Jain in the morning, Abel + Katie Farmer (BNSF) + Adam Johnson in the afternoon, moderated by Becky Quick.

Assessment: The bench broadening — particularly putting Farmer and Johnson on stage at the annual meeting — is meaningful. Berkshire is institutionalizing the post-founder communication architecture. It also raises the bar: Abel now has two named operating-CEO partners with public visibility, and they will be evaluated alongside him.

Forward Outlook

Berkshire does not provide formal numerical guidance and does not hold quarterly calls. The forward-looking content in this letter is qualitative, but several statements are specific enough to function as guidance.

Implied trajectory: 2026 insurance operating earnings should be expected to step down from the FY25 base, not just stay flat. Abel has effectively pre-announced lower premium volumes across both primary P&C and reinsurance, plus continued GEICO retention pressure. The non-insurance complex (BNSF, BHE, MSR, plus the OxyChem addition) should provide partial offset, but the mix is shifting toward steadier-but-slower-growing cash generation rather than insurance-driven leverage.

Capital deployment as the swing factor: The path to a positive earnings-revision cycle runs through Abel's capital allocation choices, not through a re-acceleration of the existing operating businesses. With $373B in cash, even modest deployment at attractive returns can be material. The watch items: (1) buyback re-acceleration if the stock weakens further; (2) any whole-business acquisitions of scale (the OxyChem precedent suggests $9–10B is in-bounds); (3) equity portfolio rotation, particularly the Bank of America position which appears under deliberate de-emphasis.

What They're NOT Saying

1. No specific 2026 numerical targets — anywhere. Even with the directional "less premium" language, there are no dollar or volume-percentage frameworks. Berkshire investors are accustomed to this, but in a CEO transition year the absence of any quantification of "less" or "for a period of time" is a meaningful information gap.
2. No 2025 buyback dollar figure or framework refresh. The criterion is unchanged but the silence on intrinsic-value methodology — and on whether the framework was ever close to triggering during 2025 — is conspicuous given the stock's pullback from May 2025 highs.
3. No explicit comment on Bank of America trims, despite its absence from the named "core" list. The omission is the message, but for a holding that ranked #3 entering 2025 the silence on rationale is notable.
4. No succession plan disclosure for Ajit Jain. Ajit is repeatedly praised in the letter but is now in his mid-70s. The letter discusses Adam Johnson's elevation, Chuck Chang as Hamburg's successor, and Mike O'Sullivan as first General Counsel — but the insurance-side leadership transition is not addressed despite being arguably the most important single succession question remaining at Berkshire.
5. No 2025 share repurchase activity at all. Zero buybacks for a calendar year is a data point. Whether by intent or by intrinsic-value math, the implied signal is that Abel did not see Berkshire shares as undervalued in 2025 — even at the post-May pullback.
6. No discussion of Apple position sizing. Apple remains the largest single holding at $62B market value, but with a cost basis of just $6.3B, the unrealized-gain math means even modest trimming has tax-leakage implications. The letter is silent on whether the position is being held, trimmed, or considered for further reduction.

Market Reaction

• Pre-print setup: BRK.B closed Friday, February 27, 2026 in the high-$490s region after a soft January–February. The stock had appreciated 10.9% in calendar 2025 vs. the S&P 500's 17.9% total return — a roughly 7-percentage-point YoY shortfall. The all-time-high close was $539.80 set on May 2, 2025 (Berkshire annual meeting day). Pre-print sell-side coverage was thin (six covering analysts) with a "Moderate Buy" consensus at a $537.75 average target. Zacks Rank entering the print was #4 (Sell) with the consensus EPS estimate showing no movement in the trailing 30 days, suggesting the Street was largely flat-footed on the magnitude of the insurance reset.
• Print reaction: Earnings released Saturday, February 28, 2026, post-market. Class A shares of the Omaha-based conglomerate slid 4.9% to start the week. The drop was driven largely by weakness in the insurance business, where underwriting profits tumbled 54% to $1.56 billion from $3.41 billion in the year-earlier period. Berkshire Hathaway B shares and A shares slid about 5% in Monday afternoon trading following news over the weekend that Q4 operating earnings dropped 30% Y/Y and new CEO Greg Abel delivered his first letter.

The ~5% Monday move is large by Berkshire standards — the stock's beta is well below 1 and single-day moves of this magnitude are uncommon outside major macro events. The market reaction reflects three concurrent disappointments: (1) the magnitude of the insurance underwriting collapse exceeded what consensus was modeling (the 8.4% revenue miss is unusually wide for Berkshire); (2) Abel's letter offered no immediate capital-deployment catalyst — no buyback re-acceleration, no large acquisition signal, no equity portfolio shake-up beyond the implicit Bank of America de-emphasis; and (3) the Q4 OTTI on Kraft Heinz and Occidental, while strategically clean, contributed to an ugly print optic. Markets were expecting either a beat or a strategic catalyst from a transition CEO; they got neither.

Street Perspective

Debate: Is the Insurance Reset Cyclical or Structural?

Bull view: The reset is purely cyclical. Combined ratios at 87.1% (FY) are still well below long-term averages of 92–93%, the float continues compounding, and Ajit Jain's discipline framework remains intact. When the cycle turns back, Berkshire will be positioned to write at attractive rates again with an even larger float base.

Bear view: GEICO's structural cost advantage is eroding. The expense ratio rose to 12.4% from a sub-10 base in 2023–2024, headcount grew nearly 5% after multi-year cuts, and competitors (State Farm, Progressive, Allstate) are improving loss ratios while GEICO's worsens. The pricing-vs.-retention trade-off may not resolve cleanly.

Our take: The cycle dimension is real and will mean-revert; the GEICO competitive-position dimension is the legitimate concern. Track GEICO's 2026 retention metrics quarter-by-quarter against Progressive's. If Progressive widens the gap on customer growth while maintaining loss-ratio discipline, the structural-erosion case strengthens.

Debate: Is the Cash Pile a Strategic Asset or a Drag on Returns?

Bull view: $373B in T-bills generates meaningful interest income at current short rates and represents true optionality. Abel's framing of "ownership of productive businesses over U.S. Treasuries" is patient discipline, not paralysis. The OxyChem deal demonstrates the pipeline is active.

Bear view: Compounding $373B at T-bill yields drags well below Berkshire's cost of equity. With no buybacks executed in 2025 and the only named acquisitions sub-$10B, the math says cash is currently a return drag. Abel may be too cautious in his first year to deploy meaningfully.

Our take: The bear case is mathematically correct in the short run; the bull case is temperamentally correct in the long run. The reconciliation depends on what Abel does in the next 12–18 months. A dry first half of 2026 with no acquisitions and continued zero buybacks would meaningfully strengthen the bear framing.

Debate: Does Abel's Continuity Posture Justify the Buffett-Era Multiple?

Bull view: Abel is signaling unmistakable continuity — same culture, same capital framework, same shareholder-orientation. The discount to historical multiples (BRK.B trading near 1.4x book vs. mid-1.5x average) is overdone. With Buffett retained as Chairman and visible in the office five days a week, the transition friction is minimal.

Bear view: Berkshire's historical premium reflected Buffett's specific capital-allocation track record, not the conglomerate structure. Abel is operations-strong but unproven at large-scale equity selection. Until he demonstrates a meaningful capital-deployment win, the multiple should compress further.

Our take: This is the central debate, and one quarter is not enough data to resolve it. The May 2026 annual meeting Q&A — Abel's first as the principal voice on stage — is the next material data point. Position-sizing should reflect this transition uncertainty: Berkshire is not the same risk profile it was 18 months ago, and the multiple compression so far is rational rather than excessive.

Model Update Needed

Valuation impact: The 2026 operating earnings step-down is the principal headwind. Offset by OxyChem inorganic, BNSF margin expansion, and float compounding, the net trajectory points to flattish-to-modestly-down operating EPS in 2026 vs. 2025. At ~1.4x book the stock is discounting most of this; the question is whether 2027 reacceleration justifies multiple expansion.

Thesis Scorecard Post-Earnings

Overall: Thesis broadly intact at the franchise level (bull #1–#3 confirmed) but with near-term operating headwinds (bear #1–#2 confirmed) that compress the next 12 months of earnings power. The Abel transition (bull #4) and GEICO competitive position (bear #4) remain "watch and wait" — not enough data yet to call either way.

Action: Initiate at Hold. Existing long-term holders have no reason to trim — the fortress is intact and Abel is signaling unmistakable continuity. New money waiting to deploy can be patient: the stock is more likely to be available at lower multiples through 2026 as the insurance cycle works through, and the next material catalyst is the May 2026 annual meeting where Abel will face direct shareholder Q&A for the first time as principal CEO. Track BNSF margin and GEICO retention as the two highest-signal operating metrics; track buyback resumption and any acquisition of >$10B scale as the two highest-signal capital-allocation tells.